|
MA Plan Rates Substantially Increased for 2026
On April 7, 2025, the Centers for Medicare & Medicaid Services (CMS) published their 2026 Rate Announcement for Medicare Advantage (MA) and Medicare Part D Prescription Drug Plans. For 2026, the payment rate to MA plans will increase 5.06%, the largest increase in the past ten years, and up significantly from the 2.2% rate increase proposed by the Biden Administration. This Health Capital Topics article will review the Rate Announcement. (Read more...)
| |
2 Fast 2 Furious: HHS Cuts on the Horizon
During the first 90 days of the Republican Party’s government trifecta (controlling the White House, Senate, and House of Representatives), both the Trump Administration and Congress have laid the groundwork for seismic change to the U.S. healthcare industry. In an attempt to track the latest actions of the federal government’s legislative and executive branches affecting the healthcare industry since the first installment in our February issue, this Health Capital Topics article summarizes recent events in Washington and the impact of these changes on providers and patients. (Read more...)
| |
Leadership on the Brink: Healthcare Executives Eyeing the Exits
While the healthcare industry has been dealing with high employee turnover since the start of the COVID-19 pandemic, that turnover was largely among clinical staff. However, a recent survey found that significant healthcare leadership turnover may also be on the horizon. AMN Healthcare subsidiary B.E. Smith found that nearly half of healthcare executives plan to leave their organization in the next year. This Health Capital Topics article reviews the survey and the reasons behind the intended exits. (Read more...)
| |
Valuation of Cardiovascular Services:
Technological Advancements
Cardiac technologies have continually evolved over the years, changing the practice and purview of cardiology providers, as well as the demand for cardiac services. By 2035, the overall prevalence of cardiovascular disease (CVD) is expected to increase from 102.7 million in 2015 to 131.2 million cases, affecting 45% of the total U.S. population, with the highest prevalence in those 65 years and older. As the cardiovascular market grows, providers can expect the types of technologies used to diagnose and treat CVD, particularly minimally invasive devices and procedures, to expand as well. This final installment of a five-part series on the valuation of cardiovascular services examines the technological advancements transforming the industry. (Read more...)
| |
HCC's Todd A. Zigrang, MBA, MHA, FACHE, CVA, ASA, ABV, and Jessica Bailey-Wheaton, Esq., were featured in the recent issue of QuckRead published by the National Association of Certified Valuators and Analysts (NACVA). This article discusses the January 2025 National Hospital Flash Report by Kaufman Hall, highlighting trends in hospital revenues, expenses, and operating margins, and examining the current financial and operational state of hospitals across the U.S.
For more recently published material written by HCC, please visit www.healthcapital.com
Read Here
| |
"Recent Court Actions Provide Insight into Future of Healthcare Fraud and Abuse Laws" authored by HCC President, Todd A. Zigrang, MBA, MHA, FACHE, CVA, ASA, ABV, and, HCC Senior Vice President and General Counsel, Jessica Bailey-Wheaton, Esq., was published by the National Association of Certified Valuators and Analysts (NACVA) in The Value Examiner.
For more recently published material written by HCC, please visit www.healthcapital.com
Read Here
| |  |
|
